My assessment - they will have to take this back to prototyping stage in a nano lab such as Stanford and develop a new basic "recipe" for the memory cells. The new recipe will have to be assessed to see if it meets the requirements for SCM before being sent off to IMEC (if IMEC want to take it on again)
Worst case - they can't make it happen - company is essentially worthless
Medium case - they can make it happen, IMEC takes it on again, but they have to go through all the process lots, non platform lots and platform lot iterations all over again. That's what, another 5 years?
Best case - the changes don't affect the process window and it is something that can be applied in addition to the etch. That's still another 2 years.
Meanwhile, any competitors in the space are advancing their NV technology.
So many unknowns - I think it's going to take a company restructure, share consolidation and more capital.
- Forums
- ASX - By Stock
- 4DS
- Ann: Company Update
Ann: Company Update, page-147
-
- There are more pages in this discussion • 151 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 4DS (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.2¢ |
Change
-0.002(2.38%) |
Mkt cap ! $144.6M |
Open | High | Low | Value | Volume |
8.5¢ | 8.8¢ | 8.2¢ | $105.8K | 1.249M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 130206 | 8.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 139429 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 130206 | 0.082 |
8 | 730456 | 0.081 |
7 | 1005933 | 0.080 |
1 | 1211 | 0.079 |
4 | 1256300 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 139429 | 2 |
0.086 | 183888 | 3 |
0.087 | 116362 | 2 |
0.088 | 115000 | 2 |
0.089 | 11000 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
4DS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online